Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Introduction: Several immune checkpoint inhibitors (CPIs) are under clinical development in hepatocellular carcinoma (HCC) and the field is advancing rapidly. In this comprehensive review, we discuss published results and report on ongoing clinical trials. Methods: A literature search was carried ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyhl-Polk, Anne, Mikkelsen, Marta Kramer, Ladekarl, Morten, Nielsen, Dorte Lisbet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234948/
https://www.ncbi.nlm.nih.gov/pubmed/34208788
http://dx.doi.org/10.3390/jcm10122662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234948/
https://www.ncbi.nlm.nih.gov/pubmed/34208788
http://dx.doi.org/10.3390/jcm10122662

Ejemplares similares